The pathway exploration in our study suggests that DO may effect multiple signaling pathways related to the pathogenesis of hyperlipidemia, including the PPAR signaling pathway, insulin resistance, AMPK signaling pathway, nonalcoholic fatty liver disease (NAFLD), and thyroid hormone signaling pathways simultaneously. The gene discussed is TG; the disease is Insulin resistance.